Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Progestin-only subdermal implants are one of the most effective contraceptive methods. Anembryonic pregnancy is not reported as a possible outcome in cases of contraceptive failure of these products. We present a rare case of anembryonic pregnancy occurring in a woman with levonorgestrel-releasing implant (JADELLE®).
Case Presentation: A 31-year-old Cameroonian (black African) housewife with a JADELLE® implant for 13 months, consulted at our hospital for a 1-month history of pelvic pain, prolonged menstrual bleeding, and spotting. She had a last normal menstrual period 8 weeks 1 day prior to presentation. On examination, there was suprapubic tenderness and blood trickling from her cervix. Despite a negative qualitative urine pregnancy test, an empty intrauterine gestational sac with mean sac diameter of 28 mm was visualized on pelvic ultrasound. Dilation and curettage with suction was done and she had complete relief from symptoms.
Conclusion: This case report highlights the possibility of anembryonic pregnancy occurring in women using the levonorgestrel-releasing subdermal implant (JADELLE®).
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924678 | PMC |
| http://dx.doi.org/10.1186/s13256-018-1675-2 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Success of Mifepristone and Misoprostol in the Management of Early Pregnancy Loss at a Community Hospital: A Prospective Study.
J Obstet Gynaecol Can
June 2025
Department of Obstetrics and Gynaecology, University of Toronto, Toronto, ON; Department of Obstetrics and Gynecology, North York General Hospital, Toronto, ON.
Objectives: This prospective single-arm study was conducted to understand the expulsion rate of the gestational sac in the management of early pregnancy loss (EPL).
Methods: We recruited 441 participants; 188 met the eligibility criteria. Participants were 18 years of age and older who experienced a confirmed EPL (<12 weeks gestational age) defined by an intrauterine pregnancy with a non-viable embryonic or anembryonic gestational sac with no fetal heart activity.
28-Year-Old Female Presenting for Pregnancy Confirmation.
J Am Coll Emerg Physicians Open
August 2025
Department of Emergency Medicine, Stanford University Hospital, Palo Alto, California, USA.
Erratum to "Investigation of amino acid profile alterations in maternal serum for early diagnosis of anembryonic pregnancy with high performance liquid chromatography-mass spectrometry" [294 (2024) 49-54].
Eur J Obstet Gynecol Reprod Biol
August 2025
Department of Nutrition Center, Capital Institute of Pediatrics, Beijing, China. Electronic address:
The effect of hereditary thrombophilia on recurrent pregnancy loss: a retrospective cohort study.
BMC Pregnancy Childbirth
November 2024
Division of Perinatology, Department of Obstetrics and Gynecology, Hacettepe University Medical Faculty, Ankara, Turkey.
Objective: Thrombophilia screening has been performed in patients with conditions such as previous fetal death, (fetal growth restriction) FGR, preeclampsia, (hemolysis. elevated liver enzyme, low platelet count) HELLP Syndrome, previous abruptio placentae, previous thrombosis in pregnancy, and abnormal placental histology. The actual role of hereditary thrombophilia in recurrent pregnancy loss (RPL) is still debated.
View Article and Find Full Text PDFPredictors of successful expectant and medical management of miscarriage: A systematic review.
Acta Obstet Gynecol Scand
December 2024
Department of Metabolism, Digestion and Reproduction, Imperial College, London, UK.
Article Synopsis
- 15.3% of pregnancies result in miscarriage, and various management options exist (expectant, medical, surgical), but individual patient factors complicate decision-making.
- The systematic review analyzed data from multiple databases up to April 2023, focusing on defined predictors for successful miscarriage management while excluding low-quality studies.
- Key findings suggest that demographics, ultrasound features, and biochemical markers influence management outcomes, with incomplete miscarriages showing a higher success rate for expectant or medical management, highlighting the need for more extensive and standardized research to aid in personalized patient care.